CFP
ABBV icon

Curran Financial Partners’s AbbVie ABBV Stock Holding History

Curran Financial Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$501K Sell
1,990
-58
-3% -$12.5K 0.07% 90
2026
Q1 		$445K Buy
2,048
+183
+10% +$40.6K 0.08% 87
2025
Q4 		$426K Hold
1,865
– – 0.08% 87
2025
Q3 		$432K Sell
1,865
-350
-16% -$71.3K 0.09% 96
2025
Q2 		$411K Sell
2,215
-159
-7% -$29.6K 0.09% 89
2025
Q1 		$497K Buy
2,374
+1
+0% +$194 0.12% 65
2024
Q4 		$422K Buy
2,373
+439
+23% +$80.7K 0.11% 67
2024
Q3 		$382K Buy
1,934
+8
+0.4% +$1.49K 0.11% 68
2024
Q2 		$330K Buy
1,926
+89
+5% +$14.7K 0.11% 66
2024
Q1 		$335K Sell
1,837
-69
-4% -$11.9K 0.12% 66
2023
Q4 		$313K Sell
1,906
-10
-0.5% -$1.46K 0.12% 63
2023
Q3 		$286K Buy
1,916
+48
+3% +$7.05K 0.12% 58
2023
Q2 		$252K Sell
1,868
-19
-1% -$2.79K 0.11% 64
2023
Q1 		$301K Buy
1,887
+8
+0.4% +$1.22K 0.14% 55
2022
Q4 		$304K Sell
1,879
-213
-10% -$32.7K 0.15% 57
2022
Q3 		$281K Sell
2,092
-7
-0.3% -$1K 0.14% 52
2022
Q2 		$321K Buy
2,099
+24
+1% +$3.67K 0.15% 49
2022
Q1 		$336K Sell
2,075
-219
-10% -$31.8K 0.14% 61
2021
Q4 		$311K Buy
+2,294
New +$271K 0.13% 58

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Curran Financial Partners's ABBV Position: Q2 2026 in Review

Curran Financial Partners reduced its AbbVie (ABBV) stake by 2.8% in Q2 2026, selling an estimated $12.5K and leaving 1,990 shares worth $501K. The position accounts for 0.07% of the portfolio, ranked #90.

Curran Financial Partners first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Curran Financial Partners held 1,990 shares of AbbVie worth $501K as of Q2 2026.
  • Curran Financial Partners sold 58 AbbVie shares in Q2 2026, an estimated $12.5K.
  • AbbVie made up 0.07% of Curran Financial Partners's portfolio in Q2 2026, its #90 holding.
  • Curran Financial Partners first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Curran Financial Partners's 13F filing for Q2 2026, filed 12 Aug 2026.